Anticancer agent 258 - CAS 2891984-12-4

Anticanceragent 258 is an imidazo[1,2-B][1,2,4]triazole derivative that modulates nuclear receptor activity. It exhibits an EC50 of 63 nM for Nurr in N2A cells and an IC50 of 0.1 pM for Nur77 in HEK293 cells. Anticanceragent 258 is applicable in studies related to cancer, metabolic disorders, and neurological diseases.

Others, Orphan Receptor

Others, GPCR/G Protein

2891968

C17H12F2N4

310.3

FC=1C=CC(=CC1)C=2N=C3N(N2)C=C(C=4C=CC=C(F)C4)N3C

-20°C

Ice Packs

Small Compound